SCHEMBL8299482

SCHEMBL8299482

N=C(S)NC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8299523 0.88
SCHEMBL8299492 0.88
SCHEMBL8345551 0.86 EPHX1 (0.50)
SCHEMBL5324177 0.86 EPHX1 (0.50)
SCHEMBL19296673 0.73 SMN1; SMN2 (0.41)
SCHEMBL5543349 0.69 SMN1; SMN2 (0.50)
SCHEMBL1588520 0.69
SCHEMBL11660924 0.69
SCHEMBL1713541 0.69
SCHEMBL20075958 0.69 NOS2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222369-B2 Process for preparing macrocyclic compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-07-17 US disclosed
EP-1730166-B1 PROCESS FOR PREPARING MACROCYCLIC DIPEPTIDES WHICH ARE SUITABLE FOR THE TREATMENT OF HEPATITIS C VIRAL INFECTIONS BOEHRINGER INGELHEIM INT (DE) 2010-03-03 EP disclosed
US-20090326194-A1 PROCESS FOR PREPARING MACROCYCLIC COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-31 US disclosed
US-7608614-B2 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-27 US disclosed
US-20080177029-A1 Process for preparing macrocyclic compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-07-24 US disclosed
US-7157424-B2 Pharmaceutical compositions for hepatitis C viral protease inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-01-02 US disclosed
WO-2004093915-A1 PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C VIRAL PROTEASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL, GMBH (DE) 2004-11-04 WO disclosed